We market well.

Your agency should fully understand your product and the science. Then, there’s the marketplace. Grasping all three dynamics is a specialized field. Ours.

Our philosophy implies there are no excuses for boring and dull. The medical industry deserves better.

Spread the word. Big or small. Any time, any place. Right now, today. Don’t wait, hesitate or ruminate. We can help all medical companies. We’d like to make your brand our next success story.

A CASE STUDY CLICK HERE
to review a copy of the book
NOW IN PROGRESS
World’s 2nd most popular
search engine? YouTube.

People are naturally interested in other humans and information.
Attract, educate and engage with videos that tell your story—just keep it brief.
SEE MORE
recent work right here
The Medical News
Major Chinese frozen food producer Sanquan Food Co Ltd said on Monday it has recalled products that may be contaminated with African swine fever, following media reports that some of its dumplings tested positive for the virus.... Japanese scientists will test the use of human-induced pluripotent stem cells (iPS) to treat spinal cord injuries, a health ministry panel that approved the research project said on Monday.... A combination of Merck & Co's immunotherapy Keytruda and Pfizer Inc's Inlyta helped patients with advanced kidney cancer live longer than those receiving and older Pfizer standalone therapy, according to data from a late-stage study presented on Saturday.... Only half of France's farmland could do without glyphosate-based weed-killers by 2021, the country's farm minister suggested, further lowering an initial ambition to get rid of the controversial chemical by then.... Indonesia will push back by as much as seven years an October deadline for halal labels on food, drugs and cosmetics, after industry voiced fears the move could bring chaos and threaten supplies of life-saving vaccines and other products.... The U.S. Centers for Medicare & Medicaid Services (CMS) on Friday proposed coverage of expensive CAR-T cell therapies at cancer centers that meet criteria including a registry or clinical study to monitor how well patients fare for at least two years after treatment.... Nektar Therapeutics said on Friday some patients with advanced bladder cancer treated with a combination of its experimental treatment and Bristol-Myers Squibb Co's immunotherapy, Opdivo, showed signs of tumor reduction in an early-stage study.... (Reuters Health) - School-age children with asthma who receive education on managing the condition may have fewer attacks, emergency room visits and hospitalizations than those who don't get such classes, a recent study suggests.... (Reuters Health) - Patients who discharge themselves from the hospital against medical advice are twice as likely to be back within 30 days as those who leave when doctors say they're ready, a large U.S. study finds.... (Reuters Health) - The number of push-ups a man can do in the doctor's office may be a good predictor of his risk of developing heart disease in the coming years, new research suggests.... (Reuters Health) - African-American adults who often struggle to pay bills may be more than twice as likely to develop heart disease than their counterparts who don't have much financial stress, a U.S. study suggests.... At least 922 children and young adults have died of measles in Madagascar since October, despite a huge emergency vaccination program, the World Health Organization (WHO) said on Thursday.... A measles outbreak that has stricken at least 225 people in New York state since October began with a traveler who visited Israel during the Jewish high holidays and returned to a predominantly ultra-Orthodox Jewish neighborhood of Rockland County.... Bayer is banking on the mild side effects of its experimental prostate cancer drug darolutamide, as it prepares to take on established rival products by Pfizer and Johnson & Johnson.... (Reuters Health) - Newborns who don't get baths right away may be more likely to be exclusively breastfed than infants who get whisked away to be washed soon after delivery, a U.S. study suggests.... (Reuters Health) - More young men and women are binge-drinking into their mid- and late-20s today than a generation ago, increasing their risk of accidental injuries, deaths and a variety of chronic illnesses, researchers say.... (Reuters Health) - Post-mammogram form letters telling women about dense breasts may be more confusing than helpful if they are difficult to read and understand, researchers say.... (Reuters Health) - Hand hygiene compliance among paramedics may be "remarkably low," according to a study that monitored ambulance workers in Scandinavia and Australia over six months.... Merck & Co Inc said on Thursday it was launching three late-stage studies for its cancer immunotherapy Keytruda as a combination treatment for prostate cancer after the drug showed anti-tumor activity in an early-stage trial.... Farmers in 45 countries still use antibiotics to boost animal growth, despite warnings from health experts and bans on the practice in many parts of the world, the World Organization for Animal Health (OIE) said on Thursday....